Phase I trial of cetuximab, intensity modulated radiotherapy (IMRT), and ipilimumab in previously untreated, locally advanced head and neck squamous cell carcinoma (PULA HNSCC)

被引：2
|
作者：
Bauman, J. [1 ]
Ferris, R. L. [2 ]
Clump, D. A. [1 ]
Ohr, J. [1 ]
Gooding, W. [1 ]
Kim, S. [2 ]
Karlovits, B. [2 ]
Duvvuri, U. [2 ]
Johnson, J. T. [2 ]
Petro, D. [1 ]
Heron, D. [1 ]
机构：
[1] UPMC, Hillman Canc Ctr, UPCI, Pittsburgh, PA USA
[2] Univ Pittsburgh, Inst Eye & Ear, Dept Otolaryngol, Div Head & Neck Surg, Pittsburgh, PA 15213 USA
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
10.1093/annonc/mdw435.31
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LBA36
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Phase I trial of cetuximab, intensity modulated radiotherapy (IMRT), and ipilimumab in previously untreated, locally advanced head and neck squamous cell carcinoma (PULA HNSCC)
    Ferris, R. L.
    Clump, D. A.
    Ohr, J.
    Gooding, W.
    Kim, S.
    Karlovits, B. J.
    Duvvuri, U.
    Johnson, J. T.
    Petro, D.
    Heron, D. E.
    Bauman, J.
    ANNALS OF ONCOLOGY, 2017, 28
  • [2] Phase I trial of cetuximab, intensity modulated radiotherapy (IMRT), and the anti-CTLA-4 monoclonal antibody (mAb) ipilimurnah in previously untreated, locally advanced head and neck squamons cell carcinoma (PULA HNSCC).
    Bauman, Julie E.
    Gooding, William E.
    Clump, David Andrew
    Kim, Seungwon
    Karlovlts, Brian J.
    Heron, Dwight Earl
    Duvvurl, Umamaheswar
    Ohr, James
    Holeva, Karen
    Ferris, Robert L.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [3] Phase I Trial of Cetuximab, Radiotherapy, and Ipilimumab in Locally Advanced Head and Neck Cancer
    Ferris, Robert L.
    Moskovitz, Jessica
    Kunning, Sheryl
    Ruffin, Ayana T.
    Reeder, Carly
    Ohr, James
    Gooding, William E.
    Kim, Seungwon
    Karlovits, Brian J.
    Vignali, Dario A. A.
    Duvvuri, Umamaheswar
    Johnson, Jonas T.
    Petro, Daniel
    Heron, Dwight E.
    Clump, David A.
    Bruno, Tullia C.
    Bauman, Julie E.
    CLINICAL CANCER RESEARCH, 2022, 28 (07) : 1335 - 1344
  • [4] Durvalumab with cetuximab and radiotherapy for locally advanced squamous cell carcinoma of the head and neck: A phase I/II trial
    Bonomo, P.
    Desideri, I.
    Mangoni, M.
    Loi, M.
    Saieva, C.
    Marrazzo, L.
    Talamonti, C.
    Salvatore, G.
    Sottili, M.
    Teriaca, M. A.
    Stocchi, G.
    Cerbai, C.
    Salvestrini, V.
    Ganovelli, M.
    Massi, D.
    Gallo, O.
    Santoro, R.
    Spinelli, G.
    Pallotta, S.
    Livi, L.
    ANNALS OF ONCOLOGY, 2020, 31 : S686 - S686
  • [5] Durvalumab with cetuximab and radiotherapy for locally advanced squamous cell carcinoma of the head and neck: A phase 1/2 trial
    Bonomo, Pierluigi
    Desideri, Isacco
    Mangoni, Monica
    Saieva, Calogero
    Loi, Mauro
    Becherini, Carlotta
    Cerbai, Cecilia
    Ganovelli, Michele
    Salvestrini, Viola
    Stocchi, Giulia
    Zani, Margherita
    Palomba, Annarita
    Livi, Lorenzo
    RADIOTHERAPY AND ONCOLOGY, 2022, 169 : 64 - 70
  • [6] Cetuximab plus radiotherapy for the treatment of locally advanced squamous cell carcinoma of the head and neck
    Griffin, S.
    Walker, S.
    Sculpher, M.
    White, S.
    Erhorn, S.
    Brent, S.
    Dyker, A.
    Ferrie, L.
    Gilfillan, C.
    Horsley, W.
    Macfarlane, K.
    Thomas, S.
    HEALTH TECHNOLOGY ASSESSMENT, 2009, 13 : 49 - 54
  • [7] Cisplatin Versus Cetuximab With Radiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck
    Husain, Zain A.
    Burtness, Barbara A.
    Decker, Roy H.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (05) : 396 - +
  • [8] Phase I evaluation of vandetanib with radiation therapy (RT) ± cisplatin in previously untreated advanced head and neck squamous cell carcinoma (HNSCC)
    Papadimitrakopoulou, V.
    Frank, S. J.
    Blumenschein, G. R.
    Chen, C.
    Kane, M.
    Cohen, E. E.
    Langmuir, P.
    Krebs, A. D.
    Lippman, S. M.
    Raben, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [9] Concurrent Weekly Cisplatin and Simultaneous Integrated Boost-Intensity Modulated Radiotherapy (SIB-IMRT) in Locally Advanced Head and Neck Squamous Cell Carcinoma (LA-HNSCC)
    Ahmed, Imtiaz
    Krishnamurthy, Sapna
    Bhise, Rohan
    Vinchurkar, Kumar
    Kalloli, Mahesh
    ORAL ONCOLOGY, 2021, 118
  • [10] Prognostic significance of epithelitis by concurrent cetuximab and radiotherapy (RT) for locally advanced head and neck squamous cell carcinoma (HNSCC) patients (Pts)
    Grau, J. J.
    Tagliapietra, A.
    Verger, E.
    Cabailero, M.
    Munoz, C.
    Alos, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
12345